ODVKYYCFYAUNFV-UHFFFAOYSA-N
C28H16ClF5N10 — CID 159965165
Data last refreshed: (MolForge compound catalog, from PubChem)
About ODVKYYCFYAUNFV-UHFFFAOYSA-N
ODVKYYCFYAUNFV-UHFFFAOYSA-N (PubChem CID 159965165) has the molecular formula C28H16ClF5N10 and a molecular weight of 622.95 g/mol. Its IUPAC name is 6-chloro-3-(6-fluoro-3-pyridinyl)imidazo[1,2-b]pyridazine;5-[3-(6-fluoro-3-pyridinyl)imidazo[1,2-b]pyridazin-6-yl]-3-(trifluoromethyl)pyridin-2-amine.
Molecular Properties
| Compound Name | ODVKYYCFYAUNFV-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 159965165 |
| Molecular Formula | C28H16ClF5N10 |
| Molecular Weight | 622.95 g/mol |
| Exact Mass | 622.12 |
| IUPAC Name | 6-chloro-3-(6-fluoro-3-pyridinyl)imidazo[1,2-b]pyridazine;5-[3-(6-fluoro-3-pyridinyl)imidazo[1,2-b]pyridazin-6-yl]-3-(trifluoromethyl)pyridin-2-amine |
| SMILES | Fc1ccc(-c2cnc3ccc(Cl)nn23)cn1.Nc1ncc(-c2ccc3ncc(-c4ccc(F)nc4)n3n2)cc1C(F)(F)F |
| InChI | InChI=1S/C17H10F4N6.C11H6ClFN4/c18-14-3-1-9(6-23-14)13-8-24-15-4-2-12(26-27(13)15)10-5-11(17(19,20)21)16(22)25-7-10;12-9-2-4-11-15-6-8(17(11)16-9)7-1-3-10(13)14-5-7/h1-8H,(H2,22,25);1-6H |
| InChIKey | ODVKYYCFYAUNFV-UHFFFAOYSA-N |
| XLogP | 6.18 |
| TPSA | 125.07 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 44 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 622.95 |
| LogP ≤ 5 | 6.18 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 10 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159965165 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.